Chlamydia trachomatis strains and virulence: rethinking links to infection prevalence and disease severity.
An unanswered question concerning prevalence and disease severity of Chlamydia trachomatis genital infection is whether more prevalent strains or strains more likely to cause serious disease complications are causally associated with specific virulence attributes. The major method for distinguishing chlamydial strains is based on differences in the major outer membrane protein (MOMP). A subset of MOMP serovars (D and E serovars) are easily the most prevalent strains identified worldwide, but MOMP serovar and genovar analyses have not yielded consistent strain-dependent virulence distinctions. Expansion of the definitions of chlamydial strains beyond the MOMP paradigm are needed to better understand virulence properties for this pathogen and how these properties reflect disease severity. Substantive genetic and phenotypic differences have emerged for the 2 major C. trachomatis pathobiotypes associated with either trachoma or sexually transmitted diseases, but differences within the sexually transmitted disease group have not yielded reliable disease severity attributes. A number of candidate virulence factors have been identified, including the polymorphic outer membrane autotransporter family of proteins, the putative large cytotoxin, type III secretion effectors, stress response proteins, and proteins or other regulatory factors produced by the cryptic plasmid. Continued work on development of a chlamydial gene transfer system and application of genomic approaches to large collections of clinical isolates will be required to associate key chlamydial virulence factors with prevalence and disease severity in a definitive way.
Byrne
Gerald I
GI
Department of Molecular Sciences, University of Tennessee Health Science Center, Memphis, TN 38163, USA. gbyrne@utmem.edu
D001426:Bacterial Proteins / Q000378:metabolism; D001427:Bacterial Toxins / Q000378:metabolism; D002690:Chlamydia Infections / Q000453:epidemiology* / Q000382:microbiology*; D002692:Chlamydia trachomatis / Q000145:classification / Q000235:genetics / Q000472:pathogenicity* / Q000502:physiology*; D006017:Glycolipids / Q000378:metabolism; D006801:Humans; D008070:Lipopolysaccharides / Q000378:metabolism; D010641:Phenotype; D018272:Porins / Q000235:genetics / Q000378:metabolism; D015995:Prevalence; D013045:Species Specificity; D013312:Stress, Physiological; D037521:Virulence Factors / Q000378:metabolism*
D001426:Bacterial Proteins; D001427:Bacterial Toxins; D006017:Glycolipids; D008070:Lipopolysaccharides; D018272:Porins; D037521:Virulence Factors; C071677:omp1 protein, Chlamydia trachomatis
Annu Rev Microbiol. 2000;54:735-74
11018143
Science. 1999 May 21;284(5418):1322-8
10334981
Proc Natl Acad Sci U S A. 1988 Jun;85(11):4000-4
2453883
Mol Microbiol. 2000 Dec;38(5):1048-60
11123678
J Immunol. 1972 Jul;109(1):116-22
4338437
Microbes Infect. 2007 Jul;9(8):947-53
17544798
JAMA. 2001 Jan 3;285(1):47-51
11150108
Infect Immun. 1998 Aug;66(8):3618-25
9673241
Microbes Infect. 2000 Apr;2(4):367-9
10817638
Microbes Infect. 2006 Mar;8(3):604-11
16527508
J Biol Chem. 1997 Apr 18;272(16):10594-600
9099706
Infect Immun. 2009 Jan;77(1):508-16
19001072
Sex Transm Dis. 2007 May;34(5):257
17483724
Infect Immun. 2006 Jan;74(1):578-85
16369014
Curr Microbiol. 2003 Mar;46(3):217-23
12567246
J Med Microbiol. 2004 Aug;53(Pt 8):735-740
15272059
J Bacteriol. 2004 Apr;186(8):2457-65
15060049
J Biol Chem. 2008 Jul 25;283(30):20674-86
18519569
J Bacteriol. 2008 Mar;190(5):1680-90
18165300
J Bacteriol. 2007 Jul;189(13):4739-48
17449608
Proc Natl Acad Sci U S A. 2009 Jan 6;106(1):292-7
19104068
J Bacteriol. 2005 Jan;187(2):443-8
15629915
Microbes Infect. 2000 May;2(6):581-92
10884608
Infect Immun. 1997 Jan;65(1):317-9
8975931
J Infect Dis. 2005 Nov 15;192(10):1836-44
16235186
J Bacteriol. 2006 Jan;188(1):275-86
16352844
Infect Immun. 1998 Apr;66(4):1317-24
9529048
J Clin Invest. 2003 Jun;111(11):1757-69
12782678
Mol Microbiol. 1995 Feb;15(4):617-26
7783634
Mol Biol Evol. 1993 Jul;10(4):892-913
8355605
Infect Immun. 2008 Jun;76(6):2273-83
18347045
Eur J Biochem. 2003 Feb;270(3):440-50
12542694
J Bacteriol. 2007 Jan;189(1):198-206
17056752
Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13984-9
11707582
J Biol Chem. 2003 May 9;278(19):17314-9
12600998
Mol Microbiol. 1999 Aug;33(4):753-65
10447885
J Infect Dis. 1995 Oct;172(4):1013-22
7561174
Trends Microbiol. 1998 Sep;6(9):370-8
9778731
J Gen Microbiol. 1993 May;139(5):1083-92
8336105
Infect Immun. 2000 Jan;68(1):360-7
10603409
Proc Natl Acad Sci U S A. 2004 Jul 6;101(27):10166-71
15199184
Plasmid. 1990 Mar;23(2):144-8
2362949
J Infect Dis. 1993 Nov;168(5):1236-40
7901289
Sex Transm Dis. 2007 May;34(5):255-6
17483723
J Immunol. 2007 Sep 15;179(6):4027-34
17785841
Infect Immun. 1993 Jun;61(6):2273-6
8500868
J Infect Dis. 1993 Jun;167(6):1379-83
8501327
Fertil Steril. 2002 Jan;77(1):162-6
11779608
J Bacteriol. 2005 Sep;187(18):6466-78
16159780
Proc Natl Acad Sci U S A. 2006 Oct 17;103(42):15599-604
17028176
J Bacteriol. 2001 Oct;183(20):5997-6008
11567000
J Exp Med. 1944 May 1;79(5):463-86
19871382
Science. 1998 Oct 23;282(5389):754-9
9784136
Emerg Infect Dis. 1996 Oct-Dec;2(4):270-88
8969244
Infect Immun. 1998 Dec;66(12):6010-3
9826386
Infect Immun. 1985 May;48(2):573-5
3988347
PLoS Pathog. 2008 Mar;4(3):e1000014
18383626
Mol Microbiol. 1997 Jul;25(2):351-9
9282747
J Infect Dis. 2001 Oct 1;184(7):879-84
11528595
J Immunol. 2000 Jan 1;164(1):13-7
10604986
Infect Immun. 2000 Jan;68(1):303-9
10603402
Genome Res. 2007 Jan;17(1):50-60
17090662
Infect Immun. 2001 Mar;69(3):1231-43
11179284
Mol Microbiol. 2006 Jan;59(2):541-50
16390448
J Bacteriol. 1987 Sep;169(9):3879-85
3040664
Proc Natl Acad Sci U S A. 2006 Jan 17;103(3):750-5
16407127
Cell Microbiol. 1999 Sep;1(2):119-30
11207546
Infect Immun. 1986 Aug;53(2):347-51
3089936
Infect Immun. 2004 Dec;72(12):7063-72
15557630
Infect Immun. 2003 Mar;71(3):1200-8
12595433
Infect Immun. 2000 Oct;68(10):5473-9
10992442
Am J Ophthalmol. 1970 Sep;70(3):367-74
4915925